Table 2.
Variables | Control group (n = 170) | VPC > 10% group (n = 203) | P-value |
---|---|---|---|
Follow-up duration (months) | 40.7 ± 24.6 | 42.3 ± 18.8 | 0.349 |
Re-admission (%) | 90 (52.9) | 115 (59.6) | 0.205 |
Total Death (%) | 0 (0) | 9 (5.3) | 0.004 |
Cardiac death (%) | 0 (0) | 2 (0.9) | |
Total thromboembolic events (%) | 7 (4.1) | 8 (4.0) | 1.000 |
CVA (new onset, %) | 7 (4.1) | 8 (4.0) | |
Peripheral thromboembolism (%) | 0 (0) | 0 (0) | |
Bleeding complications (%) | 10 (5.9) | 5 (2.5) | 0.115 |
Arrhythmic Events (%) | 8 (4.7) | 58 (28.9) | <0.001 |
AF or ATach | 8 (4.7) | 12 (5.6) | |
VT or VF | 0 (0) | 48 (23.3) |
Values are mean ± SD (range). PVC indicates premature ventricular complex; CVA, cerebrovascular accidents; AF, atrial fibrillation; ATach, atrial tachycardia; VT, ventricular tachycardia; VF, ventricular fibrillation.